A Shortened Antiepileptic Drug (AED) Course in Surgical Brain Tumor Patients: A Randomized Trial

Trial Profile

A Shortened Antiepileptic Drug (AED) Course in Surgical Brain Tumor Patients: A Randomized Trial

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 19 Oct 2017

At a glance

  • Drugs Levetiracetam (Primary)
  • Indications Seizures
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Oct 2017 Planned End Date changed from 1 Oct 2017 to 1 Sep 2020.
    • 13 Oct 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Mar 2020.
    • 20 Aug 2015 Primary endpoint changed from seizure activity to difference in neurotoxicity scale scores, also patient number changed from 234 to 82, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top